I n December 2020, mRNA vaccines leapt into the limelight as a response to the COVID-19 pandemic. To date, millions of people ...

WASHINGTON, D.C. — Despite the lightning-fast development of several COVID-19 vaccines, Operation Warp Speed is now hitting speed bumps when it comes to actually administering the needed shots. “The ...

Novavax Inc. said this week that its COVID-19 vaccine would not receive regulatory clearance in the U.S. or the U.K. until at least July, while a shortage of materials has delayed its production ...

RSV and flu mRNA vaccines struggle with lower durability, higher side effects, and weak uptake, leading to program cuts and ...